Effectiveness of Siddha drug Aswaganthi Ilagam for the management of Veluppu noi (Iron deficiency Anemia) in childre
Phase 2
- Conditions
- Health Condition 1: D509- Iron deficiency anemia, unspecified
- Registration Number
- CTRI/2023/07/055281
- Lead Sponsor
- ational Institute of Siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients willing to give blood specimen for lab investigations
Haemoglobin level within 8.1 - 10.9 gm
Blood smear shows microcytic hypochromic anemia
Patients with signs such as Pallor of skin, mucous membrane, conjuctiva and nail beds and any two of following symptoms such as lack of concentration, malaise, anorexia, headache, palpitation
Exclusion Criteria
Patient with chronic disease
Known case of any other hematological disorder
Patient not willing to give blood sample for investigation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome of the clinical study will be assessed by baseline increase in Hb level MCV MCH MCHC PCV & Serum Ferritin levels before & after treatmentTimepoint: 48th day
- Secondary Outcome Measures
Name Time Method Physiochemical analysis of the drug will be standardisedTimepoint: 6 months